The scientific and clinical basis for the treatment of Parkinson disease (2009)

CW Olanow, MB Stern, K Sethi - Neurology, 2009 - AAN Enterprises
Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the …

Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis

I Kusumi, S Boku, Y Takahashi - Psychiatry and Clinical …, 2015 - Wiley Online Library
The original definition of atypical antipsychotic drugs (APD) was drugs that are effective
against positive symptoms in schizophrenia with no or little extrapyramidal symptoms (EPS) …

Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance

B Rubí, P Maechler - Endocrinology, 2010 - academic.oup.com
In peripheral tissues, dopamine is released from neuronal cells and is synthesized within
specific parenchyma. Dopamine released from sympathetic nerves predominantly …

A Wnt1 regulated Frizzled-1/β-Cateninsignaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk …

F L'episcopo, MF Serapide, C Tirolo, N Testa… - Molecular …, 2011 - Springer
Background Dopamine-synthesizing (dopaminergic, DA) neurons in the ventral midbrain
(VM) constitute a pivotal neuronal population controlling motor behaviors, cognitive and …

Wnt/β-catenin signaling pathway governs a full program for dopaminergic neuron survival, neurorescue and regeneration in the MPTP mouse model of Parkinson's …

B Marchetti - International journal of molecular sciences, 2018 - mdpi.com
Wingless-type mouse mammary tumor virus (MMTV) integration site (Wnt) signaling is one of
the most critical pathways in developing and adult tissues. In the brain, Wnt signaling …

Akt signal transduction dysfunction in Parkinson's disease

S Timmons, MF Coakley, AM Moloney, C O'Neill - Neuroscience letters, 2009 - Elsevier
Significant attention has been drawn to the potential role of defective PI3-kinase-Akt (PKB)
signalling in Parkinson's disease (PD) neurodegeneration and to the possibility that …

Why have we failed to achieve neuroprotection in Parkinson's disease?

CW Olanow, K Kieburtz… - Annals of Neurology …, 2008 - Wiley Online Library
The development of a neuroprotective therapy that slows, stops, or reverses
neurodegeneration in Parkinson's disease (PD) is the single most important unresolved …

Levodopa: effect on cell death and the natural history of Parkinson's disease

CW Olanow - Movement Disorders, 2015 - Wiley Online Library
This review article considers the question of whether or not levodopa is toxic in Parkinson's
disease (PD). l‐dopa is the most effective symptomatic treatment for PD and has provided …

Small-molecule inhibitors of the PI3K signaling network

CR McNamara, A Degterev - Future medicinal chemistry, 2011 - Future Science
The phosphoinositide 3-kinase (PI3K) signaling pathway controls a wide variety of cellular
processes including cell death and survival, cell migration, protein synthesis and …

Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk …

F L'Episcopo, C Tirolo, N Testa, S Caniglia… - Journal of …, 2012 - Soc Neuroscience
In Parkinson's disease (PD), neurogenesis is impaired in the subventricular zone (SVZ) of
postmortem human PD brains, in primate nonhuman and rodent models of PD. The vital role …